India Pharma Outlook Team | Thursday, 18 December 2025
Bristol Myers Squibb has launched Mosaic AI content hub, a first-of-its-kind, AI-powered platform designed to reshape how pharmaceutical content is created and delivered.
Developed with Accenture, the new hub marks a major step forward in AI-driven pharmaceutical commercialization and reinforces Bristol Myers Squibb’s push toward tech-enabled patient care.
Based in Mumbai, Mosaic is an end-to-end, generative AI-enabled platform that identifies physicians’ educational needs in real time and rapidly produces patient-centric content at scale. The initiative strengthens BMS’s digital capabilities while setting a new benchmark for personalized engagement across global healthcare markets.
Also Read: Advanced Formulation Technologies Streamlining Global Pharma Innovation
The Mosaic AI content hub was inaugurated by Adam Lenkowsky, Chief Commercialization Officer of Bristol Myers Squibb, and Ndidi Oteh, Global CEO of Accenture Song.
“The future of healthcare is about meeting clinicians and patients where they are and doing so in meaningful ways. This partnership reflects our BMS approach to end-to-end digital transformation,” said Adam Lenkowsky, Chief Commercialization Officer, Bristol Myers Squibb.
“The Mosaic content hub will ultimately improve patient experience by making it easier for our marketing teams to create and share timely, tailored communications with health care professionals.”
India continues to play a strategic role in BMS’s global operations. The company recently expanded its presence with a major Hyderabad facility supporting more than 3,000 professionals across technology, drug development, supply, and enabling functions.
BMS is investing $130 million across AI initiatives in marketing and commercialization, with Mosaic as a central pillar. “We are strategically leveraging and integrating AI tools across BMS to unlock efficiency, enable access to data, boost productivity and enhance decision-making – all with the goal of helping our global workforce reinvent our industry,” said Anvita Karara, Vice President, Worldwide Commercialization Excellence.
